Novo Nordisk’s Search, Evaluation and Transactions for Partnerships in Obesity/Diabetes — Discussion on Areas of Interest, Opportunity Assessments, and Governance Processes
June 17, 2025
Breakout Session
Business Development and Investment
258A
This panel will provide a multidimensional, internal look at how different groups across Novo Nordisk collaborate to expand the options available for improving treatments of obesity and diabetes to help patients around the world.
Sponsored by: Novo Nordisk
Moderator
Speakers
.jpg)
Sponsored by:
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}